Related Experiment Video
Updated: Oct 13, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Development of Highly Sensitive Molecular Blocks at Cancer Microenvironment for Rapid Cancer Cell Death
Marie Piantino1, Masahiko Nakamoto1, Michiya Matsusaki1
1Division of Applied Chemistry, Graduate School of Engineering, Osaka University, Suita, Osaka 565-0871 Japan.
Abstract:
Improving the efficiency and selectivity of drug delivery systems (DDS) is still a major challenge in cancer therapy. Recently, the low transport efficiency of anticancer drugs using a nanocarrier due to the elimination of the carriers from the blood circulation and the blocking by tumor stromal tissues surrounding cancer cells has been reported. Furthermore, multiple steps are required for their intracellular delivery. We recently reported a cancer microenvironment-targeting therapy termed molecular block (MB) which induced cancer cell death by a pH-driven self-aggregation and cell membrane disruption at tumor microenvironment. The MB were designed to disperse as nanoscale assemblies in the bloodstream for efficient circulation and penetration through the stromal tissues. When the MBs reach the tumor site, they self-assembled in microscale aggregates on the cancer cell surfaces in response to the cancer microenvironment and induced cancer cell death. However, in vivo study in mice showed that the MB could not efficiently accumulate at the tumor site because slight hydrophobic aggregations in the bloodstream might potentially be the reason for the off-target accumulation. In this study, we optimize the hydrophilic-hydrophobic balance of MB for avoiding the off-target accumulation and for gaining higher sensitivity to the cancer microenvironment at weak acid condition. Copper-free click reaction with propiolic acid was used to reduce the hydrophobicity of the main chain and obtain higher responsive MB at cancer microenvironment for rapid cell killing. The optimized MB can be considered as a promising approach for an improved cancer cell targeting.
Insights
Optimized molecular blocks (MBs) enhance cancer drug delivery by improving tumor accumulation and targeting. This approach reduces off-target effects and increases cancer cell death through pH-responsive aggregation.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Improving drug delivery systems (DDS) for cancer therapy remains a significant challenge.
- Nanocarriers face issues like rapid blood clearance and tumor stromal tissue blockage, hindering drug transport.
- Existing methods require multiple steps for intracellular drug delivery.
Purpose of the Study:
- To optimize molecular blocks (MBs) for enhanced cancer microenvironment targeting and drug delivery.
- To improve the hydrophilic-hydrophobic balance of MBs to prevent off-target accumulation.
- To increase MB sensitivity to the acidic tumor microenvironment for efficient cancer cell killing.
Main Methods:
- Modification of MBs using copper-free click reaction with propiolic acid to tune hydrophobicity.
- Evaluation of MB performance in terms of circulation, tumor accumulation, and cancer cell targeting.
- Assessment of pH-driven self-aggregation and cell membrane disruption capabilities.
Main Results:
- Optimized MBs demonstrated reduced off-target accumulation in bloodstream.
- Enhanced sensitivity of MBs to weak acidic conditions characteristic of the tumor microenvironment.
- Successful pH-driven self-aggregation and disruption of cancer cell membranes.
Conclusions:
- Optimized MBs show improved tumor accumulation and selectivity.
- The modified MBs offer a promising strategy for enhanced cancer cell targeting and therapy.
- This approach addresses key limitations in current nanocarrier-based drug delivery systems.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway
Treatment Resistant Cancers
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

